| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8216933 | International Journal of Radiation Oncology*Biology*Physics | 2015 | 8 Pages |
Abstract
The observed effect size was smaller than hypothesized, and statistical power was limited because only 96 of the recruited 148 patients were evaluable. The primary endpoint-the change in radiation-induced xerostomia symptom burden at 9 MFR-was not significantly different between the ALTENS and PC groups. There was significantly less toxicity in patients receiving ALTENS.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Raimond K.W. MBBS, Snehal MS, Gwen PhD, RN, Stephen MD, Anurag K. MD, Khalil MD, Phuc F. MD, Sue S. MD, Joseph MD, Min MD, PhD, Ian MD, Chance L. MD, John MD, Harish MD, Stephanie L. PhD, Lawrence MD,